122 related articles for article (PubMed ID: 22588343)
1. A meta-analysis of the relationship between NAT2 polymorphism and colorectal cancer susceptibility.
Liu H; Fu ZX; Wang CY; Qian J; Xing L; Liu YW
Medicina (Kaunas); 2012; 48(3):117-31. PubMed ID: 22588343
[TBL] [Abstract][Full Text] [Related]
2. NAT2 polymorphism and gastric cancer susceptibility: a meta-analysis.
Zhong X; Hui C; Xiao-Ling W; Yan L; Na L
Arch Med Res; 2010 May; 41(4):275-80. PubMed ID: 20637371
[TBL] [Abstract][Full Text] [Related]
3. Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis.
Ying XJ; Dong P; Shen B; Wang J; Wang S; Wang G
J Cancer Res Clin Oncol; 2011 Nov; 137(11):1661-7. PubMed ID: 21877196
[TBL] [Abstract][Full Text] [Related]
4. N-acetyltransferase 2 phenotype and risk of esophageal cancer: a meta analysis.
Ma RL; Min L; Chen D; Tao WP; Ge W; Wu YG
Cancer Biomark; 2013 Jan; 13(6):447-55. PubMed ID: 24595082
[TBL] [Abstract][Full Text] [Related]
5. GSTM1-null genotype as a risk factor for sporadic colorectal cancer in a Romanian population. Association with the NAT2-rapid-acetylator phenotype and exposure to environmental factors.
Procopciuc LM; Osian G
Cancer Invest; 2014 Feb; 32(2):53-62. PubMed ID: 24467372
[TBL] [Abstract][Full Text] [Related]
6. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
7. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC
Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
[TBL] [Abstract][Full Text] [Related]
8. Relationship between metabolic enzyme polymorphism and colorectal cancer.
Chen K; Jiang QT; He HQ
World J Gastroenterol; 2005 Jan; 11(3):331-5. PubMed ID: 15637738
[TBL] [Abstract][Full Text] [Related]
9. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population.
Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Takahashi H; Kobashi G;
Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464
[TBL] [Abstract][Full Text] [Related]
10. NAT2 fast acetylator genotype and MGMT promoter methylation may contribute to gender difference in K-RAS mutation occurrence in Taiwanese colorectal cancer.
Huang CC; Chien WP; Wong RH; Cheng YW; Chen MC; Lee H
Environ Mol Mutagen; 2009 Mar; 50(2):127-33. PubMed ID: 19107910
[TBL] [Abstract][Full Text] [Related]
11. N-acetyltransferase polymorphism and risk of colorectal adenoma and cancer: a pooled analysis of variations from 59 studies.
Liu J; Ding D; Wang X; Chen Y; Li R; Zhang Y; Luo R
PLoS One; 2012; 7(8):e42797. PubMed ID: 22905173
[TBL] [Abstract][Full Text] [Related]
12. Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.
Moslehi R; Chatterjee N; Church TR; Chen J; Yeager M; Weissfeld J; Hein DW; Hayes RB
Pharmacogenomics; 2006 Sep; 7(6):819-29. PubMed ID: 16981843
[TBL] [Abstract][Full Text] [Related]
13. NAT2 fast acetylator genotype is associated with an increased risk of colorectal cancer in Taiwan.
Huang CC; Chien WP; Wong RH; Cheng YW; Chen MC; Chou MC; Lee H
Dis Colon Rectum; 2007 Jul; 50(7):981-9. PubMed ID: 17525862
[TBL] [Abstract][Full Text] [Related]
14. Association Between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results From Studies of the Past Decade and a Meta-Analysis.
Wu H; Wang X; Zhang L; Mo N; Lv Z
Clin Genitourin Cancer; 2016 Apr; 14(2):122-9. PubMed ID: 26585839
[TBL] [Abstract][Full Text] [Related]
15. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
[TBL] [Abstract][Full Text] [Related]
16. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
[TBL] [Abstract][Full Text] [Related]
17. NAT2 polymorphism and lung cancer risk: a meta-analysis.
Cui D; Wang Z; Zhao E; Ma J; Lu W
Lung Cancer; 2011 Aug; 73(2):153-7. PubMed ID: 21292342
[TBL] [Abstract][Full Text] [Related]
18. Absence of association between N-acetyltransferase 2 acetylator status and colorectal cancer susceptibility: based on evidence from 40 studies.
Zhang Lq; Zhou Jn; Wang J; Liang Gd; Li Jy; Zhu Yd; Su Yt
PLoS One; 2012; 7(3):e32425. PubMed ID: 22403658
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of NAT1 and NAT2 polymorphisms, tobacco smoking and meat consumption and risk of colorectal cancer.
Sørensen M; Autrup H; Olsen A; Tjønneland A; Overvad K; Raaschou-Nielsen O
Cancer Lett; 2008 Aug; 266(2):186-93. PubMed ID: 18372103
[TBL] [Abstract][Full Text] [Related]
20. Association Between NAT2 Polymorphisms and Lung Cancer Susceptibility.
Liu C; Cui W; Cong L; Wang L; Ruan X; Jia J; Liu Y; Jia X; Zhang X
Medicine (Baltimore); 2015 Dec; 94(49):e1947. PubMed ID: 26656326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
